BI 1839100
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Boehringer Ingelheim
Overview
BI 1839100 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
BI 1839100 clinical trials
Explore related
Medical disclaimer. This page summarizes research about BI 1839100 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.